Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 13 - Issue 6 - June 2016

Insights

Interview
An Update on the RESCUE In-stent Restenosis Trial With Dheeraj Rajan, MD
05/22/2016
Dheeraj K. Rajan, MD, FRCPC, FSIR, discusses 12- and 24-month follow-up data from the Fluency Plus Endovascular Stent Graft for In-stent Restenosis (RESCUE) study.
Dheeraj K. Rajan, MD, FRCPC, FSIR, discusses 12- and 24-month follow-up data from the Fluency Plus Endovascular Stent Graft for In-stent Restenosis (RESCUE) study.
Dheeraj K. Rajan, MD, FRCPC,...
05/22/2016
Vascular Disease Management
Interview
Inferior Vena Cava Filters in Children: An Interview With Michael J. Temple, MD
05/22/2016
Michael Temple, MD, discusses results from a multi-institutional study of inferior vena cava (IVC) filter use in children. The study’s goal was to determine success rates, complications, and outcomes as well as usage patterns for IVC filters...
Michael Temple, MD, discusses results from a multi-institutional study of inferior vena cava (IVC) filter use in children. The study’s goal was to determine success rates, complications, and outcomes as well as usage patterns for IVC filters...
Michael Temple, MD, discusses...
05/22/2016
Vascular Disease Management

Feature

Case Report
Novel Therapeutic Options in Critical Limb Ischemia and Infrapopliteal Disease Using Hybrid Atherectomy and Caged-Balloon Angioplasty
05/22/2016
The authors present a case of critical limb ischemia with nonhealing ulceration that was successfully treated with hybrid atherectomy and constrained-balloon angioplasty with excellent angiographic result and short-term follow-up.
The authors present a case of critical limb ischemia with nonhealing ulceration that was successfully treated with hybrid atherectomy and constrained-balloon angioplasty with excellent angiographic result and short-term follow-up.
The authors present a case of...
05/22/2016
Vascular Disease Management
Clinical Review
An Algorithm-Based Approach to Optimize Endovascular Outcomes of Complex Infrainguinal Peripheral Arterial Disease
05/22/2016
This manuscript evaluates current data on endovascular therapy for complex infrainguinal peripheral arterial disease and proposes an algorithm-based guideline to address the management of various lesion morphologies. 
This manuscript evaluates current data on endovascular therapy for complex infrainguinal peripheral arterial disease and proposes an algorithm-based guideline to address the management of various lesion morphologies. 
This manuscript evaluates...
05/22/2016
Vascular Disease Management

Column

Clinical Editor's Corner
Standardization of Care for Complex Peripheral Arterial Disease
05/22/2016
A standard does not yet exist for complex disease in the peripheral arteries. Interventionalists rely on small sets of data and personal experience to provide care, and the solution for this problem is still unclear.
A standard does not yet exist for complex disease in the peripheral arteries. Interventionalists rely on small sets of data and personal experience to provide care, and the solution for this problem is still unclear.
A standard does not yet exist...
05/22/2016
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

News
Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared
11/20/2024
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024....
11/20/2024
Vascular Disease Management
First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management

Advertisement

Advertisement

June 2016 Volume 13 Issue 6

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement